Wells Fargo’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4M Buy
274,311
+274,310
+27,431,000% +$11M ﹤0.01% 2003
2026
Q2
$52 Sell
1
-1
-50% -$35 ﹤0.01% 6723
2026
Q1
$64 Buy
2
+1
+100% +$34 ﹤0.01% 6554
2025
Q4
$30 Hold
1
– – ﹤0.01% 6637
2025
Q3
$29 Hold
1
– – ﹤0.01% 6614
2025
Q2
$14 Hold
1
– – ﹤0.01% 6857
2025
Q1
$29 Hold
1
– – ﹤0.01% 6568
2024
Q4
$30 Buy
+1
New +$28 ﹤0.01% 6606
2024
Q3
– Sell
-1,297
Closed -$37.1K – 6704
2024
Q2
$35.3K Buy
+1,297
New +$34.7K ﹤0.01% 5413
2024
Q1
– Sell
-1
Closed -$28 – 7249
2023
Q4
$20 Hold
1
– – ﹤0.01% 7218
2023
Q3
$16 Hold
1
– – ﹤0.01% 7278
2023
Q2
$30 Hold
1
– – ﹤0.01% 7195
2023
Q1
$29 Hold
1
– – ﹤0.01% 7269
2022
Q4
$27 Hold
1
– – ﹤0.01% 7204
2022
Q3
$0 Hold
1
– – ﹤0.01% 6881
2022
Q2
$0 Hold
1
– – ﹤0.01% 7028
2022
Q1
$0 Sell
1
-1
-50% -$26 ﹤0.01% 7311
2021
Q4
$0 Buy
+2
New +$53 ﹤0.01% 7414
2021
Q3
– Sell
-1
Closed – – 7148
2021
Q2
$0 Hold
1
– – ﹤0.01% 7065
2021
Q1
$0 Sell
1
-1
-50% -$26 ﹤0.01% 7027
2020
Q4
$0 Buy
2
+1
+100% +$25 ﹤0.01% 6650
2020
Q3
$0 Sell
1
-1
-50% -$24 ﹤0.01% 6514
2020
Q2
$0 Hold
2
– – ﹤0.01% 6466
2020
Q1
$0 Hold
2
– – ﹤0.01% 6394
2019
Q4
$0 Hold
2
– – ﹤0.01% 6484
2019
Q3
$0 Buy
2
+1
+100% +$21 ﹤0.01% 6492
2019
Q2
$0 Buy
+1
New +$21 ﹤0.01% 6444

Other funds holding FTXH

Wells Fargo's FTXH Position: Q3 2026 in Review

Wells Fargo increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 27,431,000% in Q3 2026, buying an estimated $11M and bringing the position to 274,311 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Wells Fargo first reported a position in FTXH in Q2 2019 and has held it in 27 quarters since. 71 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • Wells Fargo held 274,311 shares of First Trust Nasdaq Pharmaceuticals ETF worth $11.4M as of Q3 2026.
  • Wells Fargo bought 274,310 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2026, an estimated $11M.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #2003 holding.
  • Wells Fargo first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2019 and has held it in 27 quarters since.
  • 71 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.